AS
Ayantika Saha
About Ayantika Saha
Data last updated:
Ayantika Saha is a Director at Peoney Biotech Private Limited (since 2024), Director at Echinacea Biotech Private Limited (since 2024) and Director at Brelife Pharmaceuticals Private Limited (since 2024), and holds 1 more current directorship. The companies operate in Paper and Pharma.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 06 Dec 2024 | 2024 | Active | ||
| Director | 07 Nov 2024 | 2024 | Active | ||
| Director | 26 Jul 2024 | 2024 | Active | ||
| Director | 07 Jun 2024 | 2023 | Active |
Board colleagues of Ayantika Saha
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ravi Kapoor | 09435753 | Peoney Biotech Private Limited , Echinacea Biotech Private Limited | Director |
| Prahlad Malakar | 10683742 | Brelife Pharmaceuticals Private Limited | Director |
| Atul Kumar Shukla | 10178499 | Welicron Lifesciences Private Limited | Director |
| Rashmi Dubey | 10178500 | Welicron Lifesciences Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ayantika Saha
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ayantika Saha
Ayantika Saha currently holds 4 directorships: Peoney Biotech Private Limited (Director, since 06 Dec 2024); Echinacea Biotech Private Limited (Director, since 07 Nov 2024); Brelife Pharmaceuticals Private Limited (Director, since 26 Jul 2024); Welicron Lifesciences Private Limited (Director, since 07 Jun 2024).
Ayantika Saha was first appointed on 07 Jun 2024 as Director at Welicron Lifesciences Private Limited.
The current boards of Ayantika Saha's companies include Ravi Kapoor (Peoney Biotech Private Limited), Prahlad Malakar (Brelife Pharmaceuticals Private Limited), Atul Kumar Shukla (Welicron Lifesciences Private Limited), Rashmi Dubey (Welicron Lifesciences Private Limited).